{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:09:38Z","timestamp":1790622578613,"version":"4.1.0"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0220903","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T17:34:09Z","timestamp":1565631249000},"page":"e0220903","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy type 2B"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1734-9896","authenticated-orcid":true,"given":"Zoe","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1497-8224","authenticated-orcid":true,"given":"Nadia","family":"Milad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash Y.","family":"Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9755-1428","authenticated-orcid":true,"given":"William Wei-Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Donen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Sellers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Bernatchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,8,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/1689","article-title":"A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B","volume":"20","author":"R Bashir","year":"1998","journal-title":"Nat Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.45.4.768","article-title":"Linkage of Miyoshi myopathy (distal autosomal recessive muscular dystrophy) locus to chromosome 2p12-14","volume":"45","author":"K Bejaoui","year":"1995","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/1682","article-title":"Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy","volume":"20","author":"J Liu","year":"1998","journal-title":"Nat Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbrc.2011.10.031","article-title":"Proteomic identification of dysferlin-interacting protein complexes in human vascular endothelium","volume":"415","author":"C Leung","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nature01573","article-title":"Defective membrane repair in dysferlin-deficient muscular dystrophy","volume":"423","author":"D Bansal","year":"2003","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.expneurol.2016.06.026","article-title":"Dysferlin function in skeletal muscle: Possible pathological mechanisms and therapeutical targets in dysferlinopathies","volume":"283","author":"AM Cardenas","year":"2016","journal-title":"Exp Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/mus.24220","article-title":"Improved immunoblotting methods provide critical insights into phenotypic differences between two murine dysferlinopathy models","volume":"50","author":"AL Mueller","year":"2014","journal-title":"Muscle Nerve"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.ajpath.2014.02.005","article-title":"Lipid accumulation in dysferlin-deficient muscles","volume":"184","author":"MD Grounds","year":"2014","journal-title":"Am J Pathol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1194\/jlr.M079459","article-title":"Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B","volume":"59","author":"SL Sellers","year":"2018","journal-title":"J Lipid Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm1536","article-title":"Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states","volume":"13","author":"RD Cohn","year":"2007","journal-title":"Nat Med. United States"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/jcp.1041330319","article-title":"Inhibition of skeletal muscle satellite cell differentiation by transforming growth factor-beta","volume":"133","author":"RE Allen","year":"1987","journal-title":"J Cell Physiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0002-9440(10)63188-4","article-title":"Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis","volume":"164","author":"Y Li","year":"2004","journal-title":"Am J Pathol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.lfs.2015.10.023","article-title":"Chronic effects of losartan on the muscles and the serologic profiles of mdx mice","volume":"143","author":"E-M Lee","year":"2015","journal-title":"Life Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1111\/febs.12266","article-title":"Modifying muscular dystrophy through transforming growth factor-beta","volume":"280","author":"E Ceco","year":"2013","journal-title":"FEBS J"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002227","article-title":"Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia","volume":"3","author":"TN Burks","year":"2011","journal-title":"Sci Transl Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2044-5040-2-18","article-title":"Angiotensin II type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-alpha2-deficient congenital muscular dystrophy (MDC1A)","volume":"2","author":"S Meinen","year":"2012","journal-title":"Skelet Muscle"},{"key":"ref17","article-title":"A randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in duchenne muscular dystrophy","volume":"5","author":"HD Allen","year":"2013","journal-title":"PLoS Curr"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13395-017-0135-9","article-title":"Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy","volume":"7","author":"N Milad","year":"2017","journal-title":"Skelet Muscle"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13395-015-0057-3","article-title":"Genetic characterization and improved genotyping of the dysferlin-deficient mouse strain Dysf (tm1Kcam)","volume":"5","author":"T Wiktorowicz","year":"2015","journal-title":"Skelet Muscle"},{"key":"ref20","article-title":"Improved genotyping of the dysferlin null mouse","author":"R Han","year":"2011","journal-title":"Protoc Exch"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ajpath.2017.11.006","article-title":"Inhibition of Marfan Syndrome Aortic Root Dilation by Losartan: Role of Angiotensin II Receptor Type 1-Independent Activation of Endothelial Function","volume":"188","author":"SL Sellers","year":"2018","journal-title":"Am J Pathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"6722","DOI":"10.1093\/hmg\/ddu390","article-title":"Excess SMAD signaling contributes to heart and muscle dysfunction in muscular dystrophy","volume":"23","author":"JA Goldstein","year":"2014","journal-title":"Hum Mol Genet"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13395-016-0117-3","article-title":"Voluntary resistance wheel exercise from mid-life prevents sarcopenia and increases markers of mitochondrial function and autophagy in muscles of old male and female C57BL\/6J mice","volume":"6","author":"Z White","year":"2016","journal-title":"Skelet Muscle"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/sj.bjp.0707181","article-title":"Endothelial dysfunction and compromised eNOS\/Akt signaling in the thoracic aorta during the progression of Marfan syndrome","volume":"150","author":"AWY Chung","year":"2007","journal-title":"Br J Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/jpet.117.244244","article-title":"Effect of Ibuprofen on Skeletal Muscle of Dysferlin-Null Mice","volume":"364","author":"AF Collier","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biocel.2016.06.012","article-title":"High mTORC1 signaling is maintained, while protein degradation pathways are perturbed in old murine skeletal muscles in the fasted state","volume":"78","author":"Z White","year":"2016","journal-title":"Int J Biochem Cell Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4161\/auto.25722","article-title":"MTORC1 determines autophagy through ULK1 regulation in skeletal muscle","volume":"9","author":"P Castets","year":"2013","journal-title":"Autophagy"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/jim-2016-000102","article-title":"Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy","volume":"64","author":"A Srivastava","year":"2016","journal-title":"J Investig Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1523-1755.2005.00496.x","article-title":"Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat","volume":"68","author":"B Rodriguez-Iturbe","year":"2005","journal-title":"Kidney Int"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/1074248410381757","article-title":"Losartan decreases cardiac muscle fibrosis and improves cardiac function in dystrophin-deficient mdx mice","volume":"16","author":"CF Spurney","year":"2011","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e20856","DOI":"10.1371\/journal.pone.0020856","article-title":"Chronic losartan administration reduces mortality and preserves cardiac but not skeletal muscle function in dystrophic mice","volume":"6","author":"LT Bish","year":"2011","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2004.09.078","article-title":"Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy","volume":"45","author":"D Duboc","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1172-8-26","article-title":"Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial","volume":"8","author":"MC Walter","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e61367","DOI":"10.1371\/journal.pone.0061367","article-title":"Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin-glycoprotein complex in GRMD dogs","volume":"8","author":"KPC Araujo","year":"2013","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jns.2007.09.043","article-title":"Connective tissue growth factor is overexpressed in muscles of human muscular dystrophy","volume":"267","author":"G Sun","year":"2008","journal-title":"J Neurol Sci"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature07034","article-title":"Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells","volume":"454","author":"ME Carlson","year":"2008","journal-title":"Nature"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2044-5040-1-19","article-title":"Role of TGF-beta signaling in inherited and acquired myopathies","volume":"1","author":"TN Burks","year":"2011","journal-title":"Skelet Muscle"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neures.2005.01.006","article-title":"Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL)","volume":"52","author":"N Suzuki","year":"2005","journal-title":"Neurosci Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12017-012-8172-3","article-title":"Differential expression of genes involved in the degeneration and regeneration pathways in mouse models for muscular dystrophies","volume":"14","author":"PCG Onofre-Oliveira","year":"2012","journal-title":"Neuromolecular Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/nbm.1419","article-title":"High resolution NMR based analysis of serum lipids in Duchenne muscular dystrophy patients and its possible diagnostic significance","volume":"23","author":"NK Srivastava","year":"2010","journal-title":"NMR Biomed"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0960-8966(97)00124-7","article-title":"Muscle cells from mdx mice have an increased susceptibility to oxidative stress","volume":"8","author":"TA Rando","year":"1998","journal-title":"Neuromuscul Disord"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1152\/japplphysiol.01145.2006","article-title":"The role of free radicals in the pathophysiology of muscular dystrophy","volume":"102","author":"JG Tidball","year":"2007","journal-title":"J Appl Physiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1440-1681.2006.04394.x","article-title":"Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species","volume":"33","author":"NP Whitehead","year":"2006","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1111\/febs.12142","article-title":"Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies","volume":"280","author":"JR Terrill","year":"2013","journal-title":"FEBS J"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0149-2918(04)80049-3","article-title":"Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, doubl","volume":"26","author":"G Derosa","year":"2004","journal-title":"Clin Ther"},{"key":"ref46","first-page":"106","article-title":"Efficacy and Tolerability of Olmesartan, Telmisartan, and Losartan in Patients of Stage I Hypertension: A Randomized, Open-label Study","volume":"8","author":"M Kalikar","year":"2017","journal-title":"J Pharmacol Pharmacother"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2337\/dc07-0196","article-title":"Effect of LDL cholesterol and treatment with losartan on end-stage renal disease in the RENAAL study","volume":"31","author":"AM Tershakovec","year":"2008","journal-title":"Diabetes Care"},{"key":"ref48","first-page":"21","article-title":"Effects of antihypertensive treatment with angiotensin II receptor blockers on lipid profile: an open multi-drug comparison trial","volume":"47","author":"S-MG Kyvelou","year":"2006","journal-title":"Hellenic J Cardiol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00005344-199804000-00016","article-title":"Effects of angiotensin II-receptor blockade with losartan on insulin sensitivity, lipid profile, and endothelin in normotensive offspring of hypertensive parents","volume":"31","author":"M Lerch","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1470320310370852","article-title":"Review: angiotensin II type 1 receptor blockers: class effects versus molecular effects","volume":"12","author":"S Miura","year":"2011","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2990.1988.tb00866.x","article-title":"The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation","volume":"14","author":"GR Coulton","year":"1988","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/oxfordjournals.bmb.a071625","article-title":"Clinical biochemistry of muscular dystrophy","volume":"36","author":"RJ Pennington","year":"1980","journal-title":"Br Med Bull"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0022-510X(91)90068-I","article-title":"Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy","volume":"102","author":"M Zatz","year":"1991","journal-title":"J Neurol Sci"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e13727","DOI":"10.14814\/phy2.13727","article-title":"Diltiazem improves contractile properties of skeletal muscle in dysferlin-deficient BLAJ mice, but does not reduce contraction-induced muscle damage","volume":"6","author":"M Begam","year":"2018","journal-title":"Physiol Rep"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.2337\/db15-0472","article-title":"Direct Endothelial Nitric Oxide Synthase Activation Provides Atheroprotection in Diabetes-Accelerated Atherosclerosis","volume":"64","author":"A Sharma","year":"2015","journal-title":"Diabetes"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/hr.2015.144","article-title":"Ca2+ -regulated lysosome fusion mediates angiotensin II-induced lipid raft clustering in mesenteric endothelial cells","volume":"39","author":"W-Q Han","year":"2016","journal-title":"Hypertens Res"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1161\/ATVBAHA.112.301172","article-title":"Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy","volume":"33","author":"M Palladino","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.CIR.103.6.864","article-title":"Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin","volume":"103","author":"L Loufrani","year":"2001","journal-title":"Circulation"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00395-011-0240-6","article-title":"Vascular endothelial dysfunction in Duchenne muscular dystrophy is restored by bradykinin through upregulation of eNOS and nNOS","volume":"107","author":"H Dabire","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00109-007-0253-7","article-title":"Dysfunction of dysferlin-deficient hearts","volume":"85","author":"K Wenzel","year":"2007","journal-title":"J Mol Med (Berl)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0220903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T01:07:44Z","timestamp":1695085664000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0220903"}},"subtitle":[],"editor":[{"given":"Atsushi","family":"Asakura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,8,12]]},"references-count":60,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0220903","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,12]]}}}